Equifax SEC filings document the company’s operating results, capital structure, governance, and material corporate agreements. Recent Form 8-K reports include quarterly financial-results releases and amendments to the company’s unsecured revolving credit facility involving Equifax and subsidiary borrowers.
Regulatory records also identify Equifax common stock listed on the New York Stock Exchange under EFX. Proxy materials cover annual meeting matters, board and shareholder voting topics, executive compensation, and company discussion of data, cloud technology, security, and EFX.AI within its public-company governance framework.
Capital International Investors (CII) filed Amendment No. 7 to a Schedule 13G/A reporting beneficial ownership of 3,820,844 shares of Equifax Inc. Common Stock (CUSIP 294429105). CII states this equals 3.2% of 120,634,597 shares believed outstanding.
The filing shows CII has sole voting power for 3,770,571 shares and sole dispositive power for 3,820,844 shares. The filing is signed by Aaron Espin, Senior Vice President, dated 05/13/2026.
Equifax Inc. reported the results of its 2026 Annual Meeting of Shareholders. A total of 112,862,429 shares were represented in person or by proxy. Shareholders elected ten directors, each receiving over 99.8 million shares voted in favor and facing several million shares voted against or abstaining.
Shareholders approved, on a non-binding advisory basis, compensation for named executive officers with 90,426,432 shares for and 16,817,915 against. They also ratified Ernst & Young LLP as independent registered public accounting firm for fiscal year 2026, with 107,056,475 shares for and 5,741,059 against.
On governance matters, shareholders supported, on a non-binding advisory basis, amending the Bylaws to allow holders of at least 25% of outstanding common stock to request a special meeting, with 98,693,741 shares for. A separate shareholder proposal to reduce this threshold to 10% was not approved, receiving 38,908,801 shares for and 68,336,404 against.
EQUIFAX INC director Audrey B. Tillman received a stock-based compensation award rather than buying shares on the open market. On 5/7/2026, she acquired 1,253 shares of common stock at an indicated value of $175.62 per share as a grant under the company’s long-term incentive plan.
The award consists of restricted stock units that vest 100% on 5/7/2027 and includes dividend equivalent units credited through the company’s last dividend payment date. Following this grant, Tillman directly holds a total of 6,677 shares of Equifax common stock.
Smith Melissa D reported acquisition or exercise transactions in this Form 4 filing.
Equifax director Melissa D. Smith reported an annual equity award rather than an open‑market trade. She received a grant of 1,253 shares of common stock at $175.62 per share under the company’s long‑term incentive plan, structured as restricted stock units that vest 100% on 5/7/2027.
Following this grant, Smith directly holds 6,802 shares of Equifax common stock. A separate entry shows 1,586 shares held indirectly through the Smith Trust u/a 4/2/09, reflecting additional trust ownership rather than a new market transaction.
McKinley John A reported acquisition or exercise transactions in this Form 4 filing.
Equifax Inc. director John A. McKinley received an equity award of 1,253 shares of common stock valued at $175.62 per share as part of his annual director compensation. This grant, made under the company’s long-term incentive plan, brings his direct holdings to 34,717 shares.
The award consists of restricted stock units that vest 100% on May 7, 2027, meaning the shares will fully become his at that time if the vesting conditions are met. The holding total also includes dividend equivalent units from prior awards where dividends were reinvested into additional restricted stock units.
MCGREGOR SCOTT A reported acquisition or exercise transactions in this Form 4 filing.
Equifax director Scott A. McGregor received an equity award of 1,253 shares of common stock on May 7, 2026, recorded at $175.62 per share, as an annual director grant under the company’s long-term incentive plan. The award is structured as restricted stock units that vest 100% on May 7, 2027, meaning the shares become fully owned at that time if service conditions are met. Following this grant, McGregor directly holds 11,308 shares, which includes dividend equivalent units credited on prior restricted stock unit awards.
Equifax Inc. director Robert D. Marcus received an equity grant of 1,253 shares of common stock as a compensation award. The filing labels this as a grant or award acquisition at a reference price of $175.62 per share under the company’s long-term incentive plan.
The award consists of restricted stock units that vest 100% on May 7, 2027, and includes accrued dividend equivalent units tied to prior dividends. Following this grant, Marcus directly holds 18,349 shares of Equifax common stock.
Equifax Inc. director Barbara A. Larson received an annual equity award of 1,253 restricted stock units of common stock at a grant price of $175.62 per share. The grant was made under the company’s long-term incentive plan and is classified as an acquisition, not an open-market purchase.
The award vests 100% on May 7, 2027, aligning director compensation with longer-term performance. Following this grant, Larson directly holds 3,877 shares of Equifax common stock, which include dividend equivalent units credited on prior restricted stock unit awards.
HOUGH G. THOMAS reported acquisition or exercise transactions in this Form 4 filing.
Equifax Inc. director G. Thomas Hough received an equity award as part of his board compensation. On May 7, 2026, he was granted 1,253 shares of common stock at a grant value of $175.62 per share, described as an annual director grant under the company’s long-term incentive plan. The award consists of restricted stock units that vest 100% on May 7, 2027, and includes accrued dividend equivalent units tied to prior dividends. Following this grant, Hough directly holds 16,309 shares of Equifax common stock. This is a compensation-related award, not an open-market share purchase or sale.
Equifax director Karen L. Fichuk received an annual equity award in the form of 1,253 shares of Common Stock, recorded as a grant or award acquisition at a reference price of $175.62 per share.
The footnotes explain this is an annual director grant under the company's long-term incentive plan, structured as restricted stock units that vest 100% on 05/07/2027. Following this award, she holds 4,993 shares of Common Stock directly and 415 shares indirectly through the Karen L Fichuk Rev Trust.